Pfizer Zeldox Approval Awaits QTc Comparison To Risperdal, Zyprexa

Pfizer will compare the QTc interval prolongation of its antipsychotic Zeldox to Lilly's Zyprexa (olanzapine) and Janssen's Risperdal (risperidone) as a condition for approval.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet